BCR and diffuse large B-cell lymphoma: More recently, metabolic signatures have uncovered distinct metabolic DLBCL subsets, including the OxPhos DLBCL subset characterized by a non-functional BCR and increased mitochondrial metabolism [19], along with the BCR subset that presents an up-regulation of genes encoding BCR signaling components and enzymes associated with glycolysis [19,20].